TG Therapeutics, Inc. Shares Outstanding 2011–2025
TG Therapeutics, Inc. reported 155.3M of shares outstanding for fiscal 2025. That was 0.3% lower than fiscal 2024. Compared with fiscal 2020, the change was +10.5%. A falling share count is consistent with net buybacks exceeding issuance over the period, though the filing should be checked for the components.
| Fiscal year | Shares Outstanding | Change (YoY) |
|---|---|---|
| FY 2025 | 155.3M | -0.3% |
| FY 2024 | 155.8M | +2.9% |
| FY 2023 | 151.4M | +3.4% |
| FY 2022 | 146.4M | +2.2% |
| FY 2021 | 143.3M | +1.9% |
| FY 2020 | 140.6M | +28.5% |
| FY 2019 | 109.4M | +30.4% |
| FY 2018 | 83.9M | +14.7% |
| FY 2017 | 73.1M | +28.8% |
| FY 2016 | 56.8M | +5.0% |
| FY 2015 | 54.1M | +20.3% |
| FY 2014 | 44.9M | +31.0% |
| FY 2013 | 34.3M | +32.9% |
| FY 2012 | 25.8M | +409.9% |
| FY 2011 | 5.1M | — |
Source: TG Therapeutics, Inc. SEC filings — balance sheet (10-K), split-adjusted. Computed deterministically; refreshed nightly (last updated August 2, 2026). Open TGTX 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
TG Therapeutics, Inc. reported 155.3M of shares outstanding for fiscal 2025. That was 0.3% lower than fiscal 2024. Compared with fiscal 2020, the change was +10.5%. A falling share count is consistent with net buybacks exceeding issuance over the period, though the filing should be checked for the components. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for TG Therapeutics, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeTG Therapeutics, Inc. — frequently asked questions
What is TG Therapeutics, Inc.'s shares outstanding?
TG Therapeutics, Inc. (TGTX) reported shares outstanding of 155.3M for fiscal year 2025, per its SEC filings.
How has TG Therapeutics, Inc.'s shares outstanding changed over time?
Between fiscal 2011 and 2025, TGTX's shares outstanding grew at roughly 27.7% per year (compound annual rate), from 5.1M to 155.3M.
Where does this data come from?
Figures are computed from TG Therapeutics, Inc.'s official SEC filings (balance sheet (10-K), split-adjusted), refreshed nightly. Not investment advice.
More TGTX financial history
Full TGTX fundamentals page → · Analyze shares outstanding with a free tool → · Research guide & leaders → · All 1,500+ companies →